Pharvaris (PHVS) Earnings Date & Reports

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PHVS is expected to report earnings to rise 12.27% to -66 cents per share on August 19

Q2'26

Est.

$-0.66

Q1'26

Beat

by $0.12

Q4'25

Missed

by $0.10

Q3'25

Beat

by $0.08

Q2'25

Missed

by $0.06

The last earnings report on May 12 showed earnings per share of -58 cents, beating the estimate of -70 cents. With 24.54K shares outstanding, the current market capitalization sits at 2.31B.

View a ticker or compare two or three

Compare

PHVS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PHVS